Valuation: DexCom, Inc.

Market Cap 2.69TCr 2.37TCr 2.19TCr 2.04TCr 3.83TCr 2,53600Cr 3.9TCr 26TCr 10TCr 1,25100Cr 10TCr 9.88TCr 4,35300Cr P/E 2026 *
28.5x
P/E 2027 * 23.9x
Enterprise Value 2.65TCr 2.33TCr 2.15TCr 2.01TCr 3.77TCr 2,49800Cr 3.84TCr 26TCr 10TCr 1,23200Cr 9.95TCr 9.73TCr 4,28700Cr EV / Sales 2026 *
5.07x
EV / Sales 2027 * 4.41x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 week-0.90%
Current month-2.40%
1 month-1.19%
3 months+6.77%
6 months+8.39%
Current year+7.56%
1 week 59.52
Extreme 59.52
63.99
1 month 59.52
Extreme 59.52
68.1
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%-4.05%-18.41%-47.07% 2.66TCr
-0.04%+2.25%-34.47%-16.25% 16TCr
-0.62%+2.55%-6.91%-8.40% 10TCr
-0.53%-8.08%+52.69%+56.81% 5.48TCr
+1.20%+2.66%-3.28%+51.58% 5.47TCr
+2.68%+4.35%-13.87%-42.40% 3.97TCr
+2.12%-1.02% - - 2.98TCr
+1.20%+5.20%+52.87%-7.25% 2.38TCr
+0.73%-2.74%-18.07%-3.41% 2TCr
+1.95%+3.90%-13.53%-1.73% 1.98TCr
Average +0.98%+0.57%-0.33%-2.01% 5.59TCr
Weighted average by Cap. +0.50%+1.25%-7.70%-1.40%

Financials

2026 *2027 *
Net sales 522.48Cr 459.99Cr 424.29Cr 396.83Cr 743.51Cr 49TCr 757.39Cr 5.1TCr 1.97TCr 24TCr 1.96TCr 1.92TCr 85TCr 582.95Cr 513.23Cr 473.39Cr 442.75Cr 829.57Cr 55TCr 845.05Cr 5.69TCr 2.2TCr 27TCr 2.19TCr 2.14TCr 94TCr
Net income 96Cr 85Cr 78Cr 73Cr 136.98Cr 9.07TCr 139.53Cr 939.37Cr 363.85Cr 4.48TCr 361.4Cr 353.56Cr 16TCr 115.77Cr 101.93Cr 94Cr 88Cr 164.75Cr 11TCr 167.82Cr 1.13TCr 437.62Cr 5.38TCr 434.67Cr 425.24Cr 19TCr
Net Debt -41Cr -36Cr -33Cr -31Cr -58Cr -3.82TCr -59Cr -395.28Cr -153.1Cr -1.88TCr -152.07Cr -148.77Cr -6.55TCr -121.13Cr -106.64Cr -98Cr -92Cr -172.37Cr -11TCr -175.59Cr -1.18TCr -457.87Cr -5.63TCr -454.78Cr -444.92Cr -20TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
24/26/24 €61.50 +1.40%
23/26/23 €60.65 +0.55%
22/26/22 €60.32 -4.86%
19/26/19 €63.40 0.00%
18/26/18 €63.40 +2.16%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
69.73USD
Average target price
85.24USD
Spread / Average Target
+22.24%

Quarterly revenue - Rate of surprise